Article
|
By Ryan Memmer,
Singota Solutions
To serve client needs as pharma tech advances, a CDMO must know when to acquire new tech, increase overall instrument capacity, and maintain existing validated instrumentation.
|
|
White Paper
|
By Peter Pöchlauer,
Thermo Fisher Scientific
Once deemed an experts-only approach to chemical synthesis, flow chemistry is a cost-efficient technique growing in popularity that can increase safety and flexibility and improve product quality.
|
|
White Paper
|
By Niclas Johansson and Niklas Signer,
Cytiva
Get insights into implementing a robust business continuity management program that can help secure supply, reduce risks, and maintain quality in manufacturing operations through a crisis situation.
|
|
White Paper
|
By Barb Martinez, Damon Talley, et al.,
MilliporeSigma Process Solutions
This paper describes a robust global manufacturing network for cell culture media that supports capacity expansion to meet growing demand and ensure business continuity.
|
|
Case Study
|
By Guy Matthews,
Parker Bioscience Filtration
The development of a new product or service is better done as a collaboration between the developer and the potential end user(s).
|
|
Poster
|
By Tao Bi, Yesenia Aguilar, et al.,
JOINN Biologics
This poster reviews studies for three monoclonal antibody (mAb) drug candidates utilizing a panel of small-scale, fast, and predictive tests used to evaluate therapeutic antibodies’ developability.
|
|
Poster
|
By Michael Sibley, Angus Woodhams, et al.,
Sartorius Stedim Biotech
This poster describes the rapid transfer of Raman spectroscopy models from process development (PD) to commercial manufacturing scale, including results of process scalability tests and successful model transfer.
|
|
White Paper
|
Ajinomoto Bio-Pharma Services
Adding biologics to your pipeline requires innovative approaches to drug development and cost mitigation. Simplifying the recombinant protein production and purification processes is a good place to start.
|
|
White Paper
|
Cytiva - Cell & Gene
Here, we map out basic information to help you approach regulatory policies and offer helpful strategies to facilitate efficient regulatory review and drug approval.
|
|
Application Note
|
Pall
Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell cultures to recover extracellular proteins such as monoclonal antibodies (mAbs). This scientific brief offers an alternative.
|
|
Case Study
|
Avantor
How a sterile, closed system created process efficiency by removing the need for a biosafety cabinet and enabling the manipulation of presterilized assemblies in a more comfortable, ergonomic setting.
|
|
e-book
|
Thermo Fisher Scientific
Innovative softgel technologies that maximize your market potential: where ideation and expertise come together.
|
|
Webinar
|
Catalent
This webinar covers the key considerations for formulation screening of therapeutic proteins with a focus on maintaining protein stability and avoiding aggregation.
|
|